tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR
Advertisement

Paradigm Biopharmaceuticals (PAR) Similar Shares

Compare
26 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Paradigm Biopharmaceuticals
AU$0.33
$135.13M
43.48%
1 Buy
0 Hold
0 Sell
Moderate Buy
Opthea
AU$0.60
AU$738.77M
44.58%
0 Buy
0 Hold
0 Sell
Moderate Sell
Biotron
AU$0.01
$2.65M
-63.33%
CSL
AU$265.53
$130.54B
31.33
-11.75%
10 Buy
1 Hold
0 Sell
Strong Buy
Immutep Ltd
AU$0.28
$388.98M
-6.67%
2 Buy
0 Hold
0 Sell
Moderate Buy
Medical Developments International Limited
AU$0.72
AU$76.61M
81.25%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:PAR
Paradigm Biopharmaceuticals
0.33
0.10
43.48%
AU:OPT
Opthea
0.60
0.19
44.58%
AU:BIT
Biotron
0.01
-0.02
-63.33%
AU:CSL
CSL
265.53
-35.35
-11.75%
AU:IMM
Immutep Ltd
0.28
-0.02
-6.67%
AU:MVP
Medical Developments International Limited
0.72
0.32
80.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis